Journal of the American Heart Association · 2024 · 19 citations · 27 references
Public HealthBiostatisticsCardiologyClinical EpidemiologyEpidemiologic MethodsSurvival AnalysisAtrial FibrillationCardiovascular DiseaseCardiovascular EpidemiologyMortality ModelingSurvival ModelingTime-to-event AnalysisCox RegressionHazard Rate AnalysisHazard Rate EstimationHazard Rate ModelsHazard Ratio ModelingTime-varying Variables
BACKGROUND: Individuals with both atrial fibrillation (AF) and myocardial infarction (MI) have higher mortality compared with individuals with only 1 condition. Whether mortality differs according to the temporal order of AF and MI is unclear. METHODS AND RESULTS: We included participants from the FHS (Framingham Heart Study) from 1960 and onwards. We assessed the hazard ratio (HR) of new-onset AF and MI, and mortality according to MI and AF status (prevalent and interim) using multivariable-adjusted Cox proportional hazards models. Interim diseases were modeled as time-varying variables. For the analysis of new-onset AF, 10 923 participants (55% women; mean±SD age, 54±8 years) were included. For new-onset MI, 10 804 participants (55% women; mean±SD age, 54±8 years) were included. Compared with no MI, the hazard of new-onset AF was higher in participants with prevalent (HR, 1.60 [95% CI, 1.32-1.94]) and interim MI (HR, 3.96 [95% CI, 3.18-4.91]). Both ST-segment-elevation MI and non-ST-segment-elevation MI were associated with new-onset AF. Interim AF, not prevalent AF, was associated with higher hazard rate of new-onset MI (HR, 2.21 [95% CI, 1.67-2.92]). Interim AF was associated with both ST-segment-elevation MI and non-ST-segment-elevation MI. Mortality was significantly greater among participants with AF and MI compared with participants with 1 of the 2, regardless of temporal order. CONCLUSIONS: We report a bidirectional association between AF and MI, which was observed for both non-ST-segment-elevation MI and ST-segment-elevation MI. Participants with both AF and MI had considerably higher mortality compared with participants with only 1 of the 2 conditions, regardless of order.
27
Gerhard Hindricks, Tatjana Potpara, Nikolaos Dagres et al. · European Heart Journal · 2020 · 9.9K citations · Full text
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger, John H. Alexander, John J.V. McMurray et al. · New England Journal of Medicine · 2011 · 8.9K citations · Full text
José A. Joglar, Mina K. Chung, Anastasia L. Armbruster et al. · Circulation · 2023 · 2.4K citations · Full text
Survival after the onset of congestive heart failure in Framingham Heart Study subjects.
Kalon K.L. Ho, Karen M. Anderson, Kannel Wb et al. · Circulation · 1993 · 1.9K citations
Medicine, Biostatistics, Cardiology +12